| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 1 security · passive | ||||||
|
Coherus Oncology, Inc.
13G/A
CHRS · 19249H103
|
8.3% |
5/15/2026
Event 3/31/2026
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.